Portugal, June 11 -- Portugal based TAKEDA-Farmaceuticos Portugal, Lda has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for Antineoplastic and immunomodulating agents - 2023/0491 - VEDOLIZUMAB [300 MG; PO CONC SOL INJ; FRS]. The value of the contract is worth 25521400 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....